Form 4: Zai Lab Director William Lis Sells 15,000 ADSs Under 10b5-1 Plan

William Lis, a director of Zai Lab Ltd, sold 15,000 American Depositary Shares (ADSs) at a price of $32.98 per ADS on February 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 28, 2025, William Lis, a director of Zai Lab Ltd, executed a sale of 15,000 American Depositary Shares (ADSs) of Zai Lab.
• The sale was conducted at a price of $32.98 per ADS.
• The transaction was executed under a Rule 10b5-1 trading plan adopted on November 20, 2024.
• Following the transaction, William Lis directly owns 38,089 ADSs.
• Each ADS represents ten ordinary shares of Zai Lab.

Sentiment

Score: 5

Explanation: The document reports a routine transaction (sale of shares under a pre-arranged plan) by a company director, which is neither particularly positive nor negative. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.

Industry Context

Sales by company insiders are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates this concern.

Key Dates